Archive for the ‘clinical study retractions’ Category
The paper, “Isolated central retinal artery occlusion as an initial presentation of paroxysmal nocturnal hemoglobinuria and successful long-term prevention of systemic thrombosis with eculizumab,” had appeared in the Japanese Journal of Ophthalmology.
Energy = Renewable; Journal articles = Not renewable
Too late for a group of engineers in Iran who borrowed too liberally from previously published work in their 2013 article in Renewable and Sustainable Energy Reviews.
Two papers coauthored by the pair — who have both been found guilty of scientific dishonesty by the Danish Committees on Scientific Dishonesty — have been retracted by the FASEB Journal.
A group of cancer researchers in China has lost their 2013 paper in the International Journal of Clinical and Experimental Pathology after someone tipped off the journal that the data were copied.
The article, “Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer,” came from Ting-Ting Jiao, Ye-Min Zhang, Lin Yao, Yuan Gao, Jian Sun, Dong-Fang Zou, Guo-Ping Wu, Dan Wang, Jun Ou, Ning Hui, who work at various Shanghai hospitals.
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation.
The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its Anti-Bacterial Activity Against Staphylococcus aureus,” was written by a trio of researchers at the Center for Nanobiotechnology at VIT University in Vellore.
Xia Jiahong, an immunology researcher at Huazhong Science and Technology University in Wuhan, China, who had a paper subject to a fascinating Expression of Concern earlier this month, turns out to have had a few other entries in his retraction and correction record recently.
Here’s a retraction in the January 2014 issue of the Journal of Heart and Lung Transplantation, for “Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation,” a paper first published in 2010: Read the rest of this entry »
A group of researchers from MD Anderson Cancer Center in Houston has lost a 2013 paper in BJU International for running afoul of their institution’s ethics review board, and of military reviewers, as well.
The paper, “Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance,” looked at prostate cancer screening in men 55 and under — considered young for the older-man’s disease. According to the abstract: Read the rest of this entry »
Some Retraction Watch readers may recall this episode, recounted in a recent op-ed by Lew Powell:
During the 1980s and early ’90s a wave of nonexistent “satanic ritual abuse” claims shut down scores of day cares such as Little Rascals, McMartin in California and Fells Acres in Massachusetts. In virtually every instance the charges lacked any basis in fact. Today no reputable psychologist or other social scientist will argue otherwise. The defendants were innocent victims of a “moral panic” that bore striking similarities to the Salem witch hunts 300 years earlier.